Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 584 participants.

Also called NCT05983757

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 584 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05983757
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05983757. Randomized; single masking; primary purpose treatment. Start 2024-04-02 (actual); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
Acronym
DUSK
Intervention (Device)
Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion
Intervention (Other)
Standard medical management
Lead sponsor
Raul Nogueira (class: other)
Collaborator
Stryker Neurovascular (class: industry)
Collaborator
Brainstorme Imaging Core Lab Inc (class: not stated)

Record details

Record id
cardio:ct-nct05983757
Content hash
86ed8f7c4bf5d94b05ba6be573c1961c97af84519f2e16803fe575c50f6a8a81